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The pheromone response in the yeast Saccharomyces cerevisiae is mediated by a heterotrimeric G protein. The
Gbg subunit (a complex of Ste4p and Ste18p) is associated with both internal and plasma membranes, and a
portion is not stably associated with either membrane fraction. Like Ras, Ste18p contains a farnesyl-directing
CaaX box motif (C-terminal residues 107 to 110) and a cysteine residue (Cys 106) that is a potential site for
palmitoylation. Mutant Ste18p containing serine at position 106 (mutation ste18-C106S) migrated more rapidly
than wild-type Ste18p during sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The
electrophoretic mobility of wild-type Ste18p (but not the mutant Ste18p) was sensitive to hydroxylamine
treatment, consistent with palmitoyl modification at Cys 106. Furthermore, immunoprecipitation of the Gbg
complex from cells cultured in the presence of [3H]palmitic acid resulted in two radioactive species on
nonreducing SDS-PAGE gels, with molecular weights corresponding to Gg and Gbg. Substitution of serine for
either Cys 107 or Cys 106 resulted in the failure of Gbg to associate with membranes. The Cys 107 substitution
also resulted in reduced steady-state accumulation of Ste18p, suggesting that the stability of Ste18p requires
modification at Cys 107. All of the mutant forms of Ste18p formed complexes with Ste4p, as assessed by
coimmunoprecipitation. We conclude that tight membrane attachment of the wild-type Gbg depends on
palmitoylation at Cys 106 and prenylation at Cys 107 of Ste18p.
Heterotrimeric G proteins (containing Ga, Gb, and Gg sub-
units) are peripheral-membrane proteins that are coupled to
cell surface receptors with seven membrane-spanning domains.
They mediate response to various extracellular stimuli such as
light, odorants, and hormones. Activated receptors stimulate
exchange of GTP for GDP in Ga, resulting in dissociation of
Ga from the Gbg dimer. Subsequent events in the signal
transduction pathway are elicited either by the action of the
GTP-Ga complex or by the free Gbg. Mounting evidence
indicates that lipid modification of Ga and Gg governs their
association with membranes and in some cases promotes spe-
cific protein-protein interactions (reviewed in references 38
and 47). The C-terminal cysteine residue of mature Gg con-
tains an isoprenyl modification (either farnesyl or geranylgera-
nyl); the isoprenyl group is transferred to the cysteine residue
in the CaaX box motif of the Gg precursor, followed by pro-
teolytic removal of the last three residues and methylation of
the C terminus. In the yeast Saccharomyces cerevisiae, the pher-
omone response is mediated by Ga, Gb, and Gg subunits
(Gpa1p, Ste4p, and Ste18p, respectively) that are coupled to
either of the two pheromone receptors (Ste2p and Ste3p).
During the mating of the two haploid cell types, a cells (ex-
pressing Ste2p) and a cells (expressing Ste3p) respond to the
peptide pheromones (a-factor and a-factor, respectively) pro-
duced by cells of the opposite cell type. Free Gbg leads to
stimulation of a nitrogen-activated protein kinase cascade (26,
35). The ultimate physiological responses include arrest of cell
division and induction of mating-specific genes. Gpa1p re-
ceives both myristoyl (44) and palmitoyl (29, 43) modifications
near the N terminus. Like Ras, Ste18p contains two Cys resi-
dues near its C terminus. One Cys is contained in the farnesyl-
directing CaaX box (CTLM), and the other Cys is a potential
site for palmitoylation. Mutants with substitutions for either
Cys residue are unresponsive to pheromone (11, 15, 48), rais-
ing the possibility that the function of Gbg depends on lipid
modification of these sites.
Our previous work (20) identified three distinct populations
of Gbg: one tightly associated with plasma membranes, a sec-
ond tightly associated with internal membranes, and a third
population that is not associated (or only weakly associated)
with membranes. Binding of Ste4p to either membrane frac-
tion requires Ste18p, and plasma membrane localization also
requires Gpa1p. Two questions remain: what structural fea-
tures of Gbg determine its subcellular localization, and what
function does Gbg serve at these locations? This report ad-
dresses the first question by examining how alterations in the
residues that specify lipid modification affect the biochemical
properties and subcellular localization of the Gbg complex.
We provide evidence for palmitoylation of Ste18p and define
the roles for farnesyl and palmitoyl modifications in subcellular
localization. Our results are consistent with unpublished re-
sults of Manahan and Linder (29), who have found that Ste18p
is palmitoylated when expressed in Sf9 insect cells.
MATERIALS AND METHODS
Yeast strains and plasmids. Strains used in this study are isogenic with strain
W303-1A and are described in Table 1. Strains W303-1A, HC106S, HC107S, and
BRI1426 were transformed with the SalI-XbaI fragment of plasmid pJR868 (39)
containing ram1::HIS3 to generate strains 809-A, 810-A, 811-A, and 814-A,
respectively. PCR was used to confirm the genetic structure of the resulting
recombinants. Strains 816-1 and 817-1 were generated by selecting for 5-fluo-
roorotic acid-resistant derivatives of strains BRI1426 and 814-A, respectively.
Plasmids M70p2, M70p2C106S, and M70p2C107S (48) are high-copy-number
YEp plasmids that contain the STE181, ste18-C106S, and ste18-C107S alleles,
respectively, under transcriptional control of the ADH1 promoter. Plasmid
pBH21 contains the STE18 coding sequence under transcriptional control of the
ADH1 promoter. It was constructed by digesting high-copy-number plasmid
M91p1 (provided by M. Whiteway) with BglII and replacing the URA3-contain-
* Corresponding author. Mailing address: Department of Molecular
Genetics and Microbiology, University of Massachusetts Medical
School, 55 Lake Ave. North, Worcester, MA 01655-0122. Phone: (508)
856-2157. Fax: (508) 856-5920. E-mail: Duane.Jenness@umassmed
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ing BglII fragment with a BglII fragment containing the LEU2 gene from plasmid
YEp13 (20). Plasmid pEL37 (provided by E. Leberer) is a single-copy plasmid
that contains the HIS3 gene, as well as the STE4 and GPA1 coding sequences
under transcriptional control of the GAL1,10 promoter. Plasmid pRS313 is a
single-copy vector plasmid containing the HIS3 gene.
Reagents and culture media. YM-1 is a rich liquid medium (17). Minimal
glucose medium (18) and minimal galactose medium (20) were supplemented
with auxotrophic requirements as described previously. 2URA 1 CAA is sup-
plemented minimal glucose medium containing 0.1% casamino acids (Difco) and
lacking uracil (20). Dodecyl-b-D-maltoside, cholesterol hemisuccinate, protein
A-Sepharose beads, and hydroxylamine were from Sigma Chemical Co. Primary
and secondary antibody preparations were described previously (20).
Preparation of cleared lysates. Unless indicated otherwise, cleared lysates
were prepared from cells growing exponentially in 150 ml of YM-1 medium.
Cultures were poured over ice, and the cells were collected by centrifugation.
After two washes with ice-cold membrane buffer (10 mM Tris acetate [pH 7.6],
1 mM magnesium acetate, 0.1 mM EDTA, 8% glycerol, 0.1 mM dithiothreitol)
containing 100 mg of phenylmethylsulfonyl fluoride (PMSF)/ml and 10 mg of
pepstatin A/ml, the cells were resuspended in 0.5 ml of the same buffer and lysed
by mechanical disruption with glass beads. Unbroken cells were removed by
centrifugation for 5 min at 330 3 g. Cells containing plasmids were cultured in
2URA 1 CAA instead of YM-1. Protein concentrations were determined by
using the bicinchoninic acid reagent (Pierce).
Immunoblotting methods and quantitation. Protein samples were diluted 1:3
with sample buffer containing 50% (wt/wt) urea (20), except for the immuno-
precipitation procedure. Samples were heated for 10 min at 37°C and resolved on
either sodium dodecyl sulfate (SDS)–10% (to detect Ste4p) or SDS–18% (to
detect Ste18p) polyacrylamide gels. Gels were processed for immunoblotting,
and the proteins were detected by using a chemiluminescent reagent as described
previously (20). Results were quantified by using a densitometer (Molecular
Dynamics Corp.) and ImageQuant software.
Renografin density gradients. Membranes were fractionated on Renografin
gradients as described previously (40), except that the gradient contained pro-
tease inhibitors (100 mg of PMSF and 10 mg of pepstatin A/ml) and additional
protease inhibitors were added to the fractions at the same concentrations. The
volume of each fraction loaded on the SDS-polyacrylamide gel was proportional
to the size of the fraction.
Immunoprecipitation procedure. Cleared lysates were diluted to 8.5 mg of
protein per ml. Samples (60 ml) were adjusted to contain 2 mg of dodecyl-b-D-
maltoside/ml, 0.4 mg of cholesterol hemisuccinate/ml, and 0.25 M NaCl. After
160 min on ice, insoluble material was removed by 10 min of centrifugation in an
IEC/MicroMax microcentrifuge. One 30-ml aliquot was mixed with 15 ml of
packed protein A-Sepharose beads (Sigma) that had been coated with anti-Ste4p
antiserum, and a second 30-ml aliquot was mixed with 15 ml of uncoated beads.
Beads and lysates were incubated overnight at 4°C with continuous mixing,
collected by centrifugation, and then washed three times with a buffer containing
20 mM Tris acetate (pH 7.6), 1 mM magnesium acetate, 250 mM NaCl, 2 mg of
dodecyl-b-D-maltoside/ml, and 0.4 mg of cholesterol hemisuccinate/ml. Immune
complexes were eluted from the washed beads by incubation in sample buffer
(50 mM Tris-Cl [pH 6.8], 2% SDS, 10% glycerol, bromophenol blue) for 5 min
at 65°C. The supernatant fraction (containing the proteins that had not bound to
the protein A-Sepharose beads) was mixed with one-half volume of 33 SDS
sample buffer (25) and incubated for 5 min at 65°C. Ste18p was detected by
immunoblotting methods.
[3H]palmitic acid labeling. Cultures were labeled with [3H]palmitic acid, and
Ste18p was analyzed essentially as described by Song and Dohlman (43) for
Gpa1p. Strains W303-1A, HC106S, and BRI1426 were cultured overnight in
minimal glucose medium at 30°C and concentrated to 108 cells/ml. A 10-ml
volume of culture was incubated for 2 h with 5 mCi of [3H]palmitic acid (50
Ci/mmol) in the presence of the fatty acid synthesis inhibitor cerulenin (2 mg/ml).
The levels of incorporation of radioactivity into the cells were 54, 51, and 60%,
respectively, for the three cultures. As described above for the immunoprecipi-
tation procedure, the cells were disrupted with glass beads, cleared lysates were
prepared, membrane proteins were solubilized with detergent, and complexes
containing Ste4p were precipitated with anti-Ste4p antiserum. Half of the prep-
aration was resolved on each of two nonreducing SDS–18% polyacrylamide gels.
One gel was fixed and treated with 1 M Tris-HCl, pH 7, and the other was treated
with 1 M NH2OH, pH 7, as described elsewhere (43). Gels were processed for
autoradiography by using Entensify universal autoradiographic enhancer (NEN
Life Sciences) and exposed for 3 months at 280°C. Diploid strain W303 con-
taining plasmids pBH21 and pEL37 and the control strain containing plasmids
pBH21 and pRS313 were processed identically except that minimal galactose
medium was used for both strains and levels of incorporation of radioactivity
were 34 and 33%, respectively.
Hydroxylamine treatment of cleared lysates. Cleared lysates were prepared as
described above except that the cells were disrupted in a buffer containing 10
mM Tris acetate (pH 7.6), 2 mM EDTA, 0.1 mM dithiothreitol, 100 mg of
PMSF/ml, and 10 mg of pepstatin A/ml. Samples were diluted to 5 mg of protein
per ml, treated with an equal volume of 0.5 M hydroxylamine, incubated for 45
min at 30°C, and then processed for SDS-polyacrylamide gel electrophoresis
(PAGE) and immunoblotting.
RESULTS
Electrophoretic mobilities and relative abundance of the
ste18 mutant proteins. Proteins containing the C-terminal
CaaX box motif are subject to a series of posttranslational
processing steps consisting of prenylation of the cysteine fol-
lowed by proteolysis of the aaX residues and carboxylmethy-
lation of the prenylated cysteine. When the CaaX motif con-
tains methionine, serine, or glutamine in the X position, it
specifies farnesylation of the cysteine residue, whereas se-
quences containing leucine in the X position specify gera-
nylgeranylation (reviewed in reference 49). As for mammalian
Ras, the yeast Ras1p and Ras2p proteins each contain a far-
nesyl-directing CaaX box. Most Ras proteins are palmitoylated
near the C terminus (16); both of the yeast Ras proteins are
palmitoylated at a cysteine immediately adjacent to the preny-
lated cysteine (4). Palmitoylation depends on prior prenylation
(8, 16). Ste18p also contains a farnesyl-directing CaaX box and
an adjacent cysteine (Fig. 1A), raising the possibility that both
cysteine residues receive lipid modifications. Mutations result-
ing in replacement of either cysteine by serine lead to extreme
defects in mating (11, 15, 48). We sought to determine how
these mutations in the CaaX motif change the chemical struc-
ture and the biochemical properties of Ste18p. To assess
TABLE 1. Strain list
Straina Genotype
W303-1A..........................................................................................................MATa ade2 his3 leu2 trp1 ura3 can1
HC106S............................................................................................................W303-1A ste18-C106S
HC107S............................................................................................................W303-1A ste18-C107S
BRI1426...........................................................................................................W303-1A ste18::URA3
809-A................................................................................................................W303-1A ram1::HIS3
810-A................................................................................................................W303-1A ram1::HIS3 ste18-C106S
811-A................................................................................................................W303-1A ram1::HIS3 ste18-C107S
814-A................................................................................................................W303-1A ram1::HIS3 ste18::URA3
816-1/M70p2....................................................................................................W303-1A ste18::ura3 containing plasmid M70p2
816-1/M70p2C106S.........................................................................................W303-1A ste18::ura3 containing plasmid M70p2C106S
816-1/M70p2C107S.........................................................................................W303-1A ste18::ura3 containing plasmid M70p2C107S
817-5/M70p2....................................................................................................W303-1A ste18::ura3 ram1::HIS3 containing plasmid M70p2
817-5/M70p2C106S.........................................................................................W303-1A ste18::ura3 ram1::HIS3 containing plasmid M70p2C106S
817-5/M70p2C107S.........................................................................................W303-1A ste18::ura3 ram1::HIS3 containing plasmid M70p2C107S
W303 (diploid)................................................................................................MATa/MATa ade2/ade2 his3/his3 leu2-/leu2 trp1/trp1 ura3/ura3 can1/can1
a Strains HC106S and HC107S were from M. S. Whiteway (48). Strain BRI146 was also kindly provided by M. S. Whiteway. All other strains were generated during
the course of this study.
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changes in chemical structure, we examined the mobilities of
the wild-type and mutant proteins on SDS-polyacrylamide gels.
We reasoned that mutations affecting farnesylation at Cys 107
or a second modification at Cys 106 might cause detectable
changes in the electrophoretic mobility of Ste18p.
Previous studies investigating the electrophoretic mobility of
Ste18p were limited to fusion proteins that had been overpro-
duced (11, 13). Under these conditions, the mobility of Ste18p
was slower in the ste18-C107Y mutant (13) and in a ram1
mutant defective in farnesyltransferase activity (11). In the
present study, we analyzed the mobilities and levels of accu-
mulation of mutant forms of Ste18p that had been expressed
under the control of the native promoter at the normal chro-
mosomal location. Because the antiserum was directed against
the N terminus of Ste18p (20), it was unnecessary to use an
epitope-tagged form of the protein. Cleared lysates were pre-
pared from the various mutant cells, and proteins were re-
solved by SDS-PAGE and detected by immunoblot analysis
(Fig. 1B). The mutant protein encoded by mutant allele ste18-
C107S migrated more slowly than wild-type Ste18p. The mo-
bility shift potentially reflected changes in lipid modification,
failure to cleave the C-terminal residues, or the amino acid
substitution itself. The reduced mobility of the ste18-C107S
mutant protein is consistent with the loss of prenylation at Cys
107, as proposed previously (11, 13). In contrast, the ste18-
C106S mutant protein migrated more rapidly than wild-type
Ste18p, suggesting that this mutation causes a defect in a pro-
cessing event other than farnesylation.
The relative abundances of the Ste18p proteins in the dif-
ferent mutant and wild-type strains were estimated by compar-
ing the intensities of the Ste18p bands on the immunoblot with
respect to the amount of total protein analyzed (Fig. 1B). Only
the ste18-C107S mutant showed a consistent reduction in the
abundance of Ste18p. In four independent analyses, the ste18-
C107S mutant protein was detected at a level that was 10 to
20% of the level of Ste18p from the wild-type control strain.
Thus, prenylation of wild-type Ste18p may be essential for
maintaining the stability of Gg; the faster-migrating minor
species detected in the ste18-C107S mutant may represent a
degradation intermediate. The ste18-C106S mutant protein
was relatively abundant (between 25 and 60% of the level of
the wild type).
The ste18-C106 mutant protein, but not the ste18-C107 mu-
tant protein, is a substrate for farnesylation. The electro-
phoretic mobilities of the Ste18p proteins in the various mu-
tant strains (Fig. 1B) reflect structural differences among the
mutant proteins but do not identify the underlying chemical
changes. To assess the chemical structure, we examined
whether the electrophoretic mobility was sensitive to condi-
tions which either block or remove specific lipid modifications
(i.e., farnesylation or palmitoylation). As a test for farnesyla-
tion of the ste18-C106S and ste18-C107S mutant proteins, we
asked whether the electrophoretic mobility of the mutant pro-
tein was sensitive to the presence of the farnesyltransferase
encoded by the RAM1 gene. When overexpressed in a ram1
mutant, epitope-tagged Ste18p is known to migrate more
slowly on SDS-PAGE gels (11). We examined the effect of the
ram1 mutation on the mobilities of overexpressed ste18-C106S
and ste18-C107S mutant proteins and wild-type Ste18p (Fig.
2A). High-copy-number derivatives of plasmid M70p2 contain-
ing the STE181, ste18-C106S, and ste18-C107S alleles were
introduced into RAM1 and ram1D strains that carried a dis-
ruption of the chromosomal STE18 gene. Consistent with the
previous observation (11), the mobility of wild-type Ste18p was
slower in the ram1D strain (Fig. 2A). Furthermore, our results
indicate that the modification requires Cys 107 since the mo-
bility of the ste18-C107S mutant protein was not affected by the
ram1D mutation. In contrast, Cys 106 was not required for
farnesylation since the mobility of the ste18-C106S mutant
protein was strongly affected by the ram1D mutation. Thus,
when overexpressed, the ste18-C106S but not the ste18-C107S
mutant protein is a substrate for farnesylation. Moreover, the
modification that occurs at Cys 106 apparently occurs after
farnesylation of Cys 107, since the ste18-C106S mutant protein
migrates faster than wild-type Ste18p when produced in the
RAM11 strain (Fig. 2A; compare lanes 5 and 7) but not when
produced in the ram1D strain (compare lanes 4 and 6).
We also tested the effect of the ram1D mutation on the
mutant Ste18p proteins when the allele contained the native
promoter at the normal chromosomal location (Fig. 2B). As
for the overproduced proteins, the ste18-C106S mutant pro-
tein, but not the ste18-C107S mutant protein, showed an
electrophoretic pattern that was altered in the ram1 mutant.
FIG. 1. SDS-polyacrylamide gel analysis of the ste18 mutant proteins. (A)
C-terminal sequence of Ste18p precursor predicted from nucleic acid sequence.
(B) Immunoblotting analysis performed on cleared lysates of exponentially grow-
ing cells. The STE18 allele designations are listed across the top. Amounts of
protein loaded (from left) were as follows: ste18::URA3 (null), 33 mg; STE181, 5
mg; ste18-C107S, 33 mg; STE181, 5 mg; STE181, 5 mg; ste18-C106S, 10 mg; and
STE181, 5 mg. Strains used were BRI1426, W303-1A, HC107S, and HC106S.
FIG. 2. Immunoblot analysis of the ste18-C106S and ste18-C107S mutant
proteins synthesized in the absence of farnesyltransferase. (A) Mutant and wild-
type Ste18p overexpressed in RAM11 and ram1D host strains. The plasmid-
bearing strains were grown to exponential phase in 20 ml of selective medium;
0.25-ml volumes of cleared lysates were used for immunoblotting analysis. Lanes
were loaded with 3 to 6 mg of total protein. Strains used were 816-1/M70p2,
817-5/M70p2, 816-1/M70p2C106S, 817-5/M70p2C106S, 816-1/M70p2C107S, and
817-5/M70p2C107S. (B) Mutant and wild-type Ste18p expressed at the normal
level. Strains containing a single copy of STE181, ste18-C106S, or ste18-C107S at
the normal chromosomal locus were processed as for panel A. Strains used and
quantities of total protein analyzed were as follows: W303-1A, 7 mg; 809-A, 12
mg; HC106S, 19 mg; 810-A, 26 mg; HC107S, 41 mg; 811-A, 34 mg; and W303-1A,
7 mg.
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However, unlike the overproduced protein, relatively minor
changes in mobility were observed for wild-type Ste18p from
the ram1 mutant. Moreover, the Ste18p from the STE181
ram1 strain was more abundant than that from the ste18-C107S
strain, it did not exhibit the same degradation product, and it
did not migrate to the same position. Thus, in the absence of
farnesyltransferase activity, wild-type Ste18p received a modi-
fication that was not detected when the protein was overpro-
duced; this modification required the presence of both Cys 106
and Cys 107 (Fig. 2B; compare lanes 2, 4, and 6). Possible
modifying activities include either geranylgeranyltransferase
type I (GGTase I) or GGTase II. Cross-specificity of the far-
nesyltransferase and GGTase I enzymes has been reported
(32, 45, 49).
Palmitoyl modification at Cys 106. We considered the pos-
sibility that Cys 106 is a site for palmitoylation and that the
increased mobility of the ste18-C106S mutant protein is due to
the loss of this modification. Palmitoylation of cysteine resi-
dues occurs through a thioester linkage, which is cleaved by
treatment with neutral hydroxylamine (27). As a preliminary
test for palmitoylation of Ste18p, we examined whether Ste18p
becomes labeled when cells are cultured in the presence of
radioactive palmitic acid. The Gbg complexes that had been
solubilized with detergent and precipitated with anti-Ste4p an-
tiserum were resolved by nonreducing SDS-PAGE (Fig. 3A).
Nonreducing conditions were maintained to avoid potential
cleavage of the thioester linkage by thiol reducing agents.
Wild-type cells (lane 1) gave two radioactive species that were
not observed for the ste18-C106S and ste18::URA3 control cells
(lanes 2 and 3, respectively). The molecular masses of these
species were consistent with Gg (13 kDa) and Gbg (60 kDa)
dimers. Similar labeled species were obtained with cells over-
producing Ste4p and Ste18p (lane 5), but not with control cells
lacking Ste4p (lane 4). Nearly all of the label was released from
these species when the gel was incubated in hydroxylamine
(data not shown). These results are consistent with at least
some of the Ste18p molecules containing a palmitoyl modifi-
cation. To determine whether the bulk of the Ste18p molecules
contained a hydroxylamine-sensitive modification at Cys 106,
we tested whether the electrophoretic mobilities of Ste18p and
the ste18-C106S mutant were altered by hydroxylamine treat-
ment (Fig. 3B). If the aberrant mobility of the mutant protein
was due to its failure to receive a palmitate moiety, then the
mobility of the wild-type protein, but not that of the mutant
protein, should increase upon hydroxylamine treatment.
Cleared lysates were incubated with neutral hydroxylamine
and then processed for SDS-PAGE. The mobility of Ste18p,
but not that of the ste18-C106S mutant protein, increased fol-
lowing hydroxylamine treatment; the treated wild-type protein
comigrated with the mutant protein. This result indicates that
essentially all Ste18p molecules contain a thioester linkage at
Cys 106.
ste18 mutant proteins form Gbg complexes with Ste4p.
Lipid modifications of proteins potentially influence their in-
teraction with membranes or with other proteins. We used
coimmunoprecipitation to test whether formation of the Gbg
complex requires lipid modification of Ste18p. Cleared lysates
from the ste18 mutant and wild-type control cells were ex-
tracted with the detergent dodecyl-b-D-maltoside and then in-
cubated with anti-Ste4p antiserum. The supernatant fractions
and pellet fractions were assayed for Ste18p by immunoblot-
ting methods (Fig. 4). Each mutant Ste18p was found in the
pellet fraction after Ste4p had been immunoprecipitated with
anti-Ste4p antibody, thus indicating the presence of Gbg com-
plexes. Quantification of the amount of Ste18p remaining in
the supernatant after antibody treatment indicated that immu-
noprecipitation of each mutant protein was as efficient as that
of the wild-type protein (about 80%). This experiment dem-
onstrates that changes in the lipid modification of Ste18p do
not prevent Gbg complex formation. Similar results have been
obtained for mammalian Gbg subunits (22, 31, 42).
Both Cys 106 and Cys 107 are required for stable associa-
tion of Gbg with membranes. To test whether the ste18 mu-
tations result in changes in the membrane localization of Gbg,
we fractionated membranes from the various ste18 mutants on
FIG. 3. Evidence for palmitoylation of Ste18p. (A) [3H]palmitate labeling of
Ste18p. A nondenaturing detergent was used to extract proteins from cells that
had been cultured in the presence of [3H]palmitic acid, Gbg complexes were
precipitated with anti-Ste4p antiserum, and the proteins were resolved by non-
reducing SDS-PAGE and then detected by autoradiography. Strains used were
as follows: lane 1, wild-type haploid cells (W303-1A); lane 2, ste18-C106S mutant
cells (HC106); lane 3, ste18::URA3 cells (BRI1426); lane 4, MATa/MATa dip-
loid control cells (W303) expressing Ste18p (plasmid pBH21) but not Ste4p; and
lane 5, MATa/MATa diploid cells (W303) expressing both Ste18p and Ste4p
(plasmids pBH21 and pEL37, respectively). (B) Thioester-linked modification of
Cys 106. Cleared lysates of strains containing STE181 (Wild Type), ste18-C106S
(C106S), or ste18D::URA3 (Null) were either untreated (2) or treated with
hydroxylamine (1) as indicated. Ste18p was analyzed by SDS-PAGE and immu-
noblotting. Strains used were W303-1A, HC106S, and BRI1426.
FIG. 4. Mutant ste18 proteins form Gbg complexes. Detergent-solubilized
lysates were incubated with protein A-Sepharose beads that were either uncou-
pled (2) or had been precoupled with anti-Ste4p antiserum (1). The presence
of Ste18p in the supernatant (Sup) and pellet fractions was tested by SDS-PAGE
and immunoblotting. Strains used were W303-1A, HC106S, and HC107S.
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Renografin density gradients and assayed the fractions for
Ste4p and Ste18p. Renografin density gradients resolve plasma
membranes, internal membranes, and nonmembrane proteins
(23, 40). Previously, we have shown that Ste4p and Ste18p from
wild-type cells are associated with all three fractions (20).
However, in the ste18-C106S mutant, Ste4p and Ste18p were
not associated with either membrane fraction (Fig. 5B). Since
the ste18-C106S mutant protein is apparently farnesylated (Fig.
2), our results indicate that farnesylation of Ste18p is not suf-
ficient to promote stable association of Gbg with membranes;
we cannot rule out the possibility that the mutant protein is
associated weakly with membranes in vivo and is released dur-
ing analysis. In the ste18-C107S mutant, the Gbg complexes
were no longer associated with plasma membranes or with
internal membranes (Fig. 5C). Because the ste18-C107S mu-
tant protein was not as abundant as the wild-type Ste18p, we
were unable to evaluate its distribution in the gradient. When
a strain (816-1/M70p2C107S) that overproduces the ste18-
C107S mutant protein was examined, Ste4p and the mutant
Ste18p were detected only in the dense fractions that con-
tained no membranes (data not shown). The ste18-C107S and
ste18-C106S mutant proteins, which formed Gbg complexes
but failed to associate with membranes (Fig. 5), also failed to
promote the pheromone response and mating (48).
DISCUSSION
This study explored the role that covalent lipid modifications
play in the localization of the yeast Gbg complex. Previous
workers established that residues of the CaaX motif and the
neighboring cysteine residue (Cys 106) are important for the
activity of Ste18p (15, 48) and that Ste18p receives a farnesyl
modification (11). Our results provide evidence for a thioester
lipid modification at Cys 106. This lipid modification is likely to
be palmitoyl since yeast Ras is palmitoylated at a similar po-
sition and since Ste18p can be labeled with [3H]palmitic acid in
a manner that is hydroxylamine sensitive and dependent on
Cys 106. As for mammalian G proteins (30, 42), prenylation of
yeast Gg is essential for membrane attachment but not for
binding Gb. Unlike other known Gg subunits, Ste18p appar-
ently requires an additional palmitoyl modification for local-
ization and function.
Ste18p is similar to the yeast Ras proteins (encoded by RAS1
and RAS2) in several respects. Both proteins contain a cysteine
immediately adjacent to a farnesyl-directing CaaX motif, and
the palmitoyl moiety is added only after farnesylation (8). Like
Ras (1, 4), palmitoylation of Ste18p is essential for localization
to the plasma membrane. Both unpalmitoylated Ras (1, 4, 6)
and ste18-C107S mutant protein (48) exhibit biological activity
that is significantly reduced but not eliminated. Thus, the mem-
brane localization that is afforded by the palmitoyl moiety
appears to facilitate interaction with other components of the
signal transduction pathway but is not absolutely required. In
yeast, the same farnesyltransferase (a and b subunits, encoded
by RAM2 and RAM1, respectively) operates on Ras, Ste18p,
and the a-factor pheromone (11, 12, 19, 34).
Ste18p is unusual among Gg proteins in that the C-terminal
isoprenyl group is farnesyl. Although transducin g (13) and,
apparently, g11 (36) are substrates for farnesyltransferase, all
other Gg subunits are modified by GGTase I (49). We are
unaware of other Gg subunits that contain Cys adjacent to the
prenylation site. Previous genetic tests (48) suggest that farne-
sylation is not absolutely required for Ste18p function, since
the ram1 mutant, which lacks farnesyltransferase, shows only a
minor reduction in pheromone responsiveness. Moreover, mu-
tant Ste18p proteins from these strains showed only slightly
slower electrophoretic mobilities than Ste18p from wild-type
cells, yet the mobility was faster than the ste18-C107S mutant
protein or the Ste18p that had been overproduced in the ram1
mutant (Fig. 1 and 2). Together these results raise the possi-
bility that an enzyme other than farnesyltransferase modifies
Cys 107 and that the activity modifies a significant portion of
Ste18p when overproduced. Possible modifying activities in-
clude either GGTase I or GGTase II. GGTase I potentially
modifies Ste18p in the ram1 mutant, since farnesyltransferase
and GGTase I exhibit some cross-specificity (32, 45, 49). How-
ever, the alternative modification that operates on wild-type
Ste18p in the ram1 mutant apparently requires both Cys 106
and Cys 107 (Fig. 2B). This result suggests a role for GGTase
II, since this enzyme has been shown to modify both paired
cysteines within several C-terminal motifs (2XXCC, 2XCXC,
or 2CCXX) that are found among Rab proteins (9); however,
potential substrates containing the motif 2CCXXX have not
FIG. 5. Association of mutant and wild-type Ste18p proteins with internal
and plasma membranes. Membranes from mutant and wild-type strains were
fractionated on a Renografin gradient. Fractions were assayed for Ste4p (open
circles), Ste18p (filled squares), and plasma membrane ATPase (dashed line) by
immunoblotting methods. The ste18-C107S mutant protein was below the de-
tectable level in the gradient fractions. (A) Strain W303-1A (STE181). (B) Strain
HC106S (ste18-C106S). (C) Strain HC107S (ste18-C107S).
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been examined. The partial activity of the ste18 truncation
mutant lacking the three C-terminal residues (i.e., containing
2XXCC) (48) is consistent with modification by GGTase II.
Association of yeast casein kinase I (Yck1p) with the plasma
membrane also depends on the motif 2XXCC (46). However,
a potential problem for the proposal that GGTase II modifies
Ste18p and Yck1p is that Rab proteins are substrates for
GGTase II only when they have bound the guanine nucleotide
dissociation inhibitor-like protein REP1, and short pep-
tides containing the prenylation motif are not recognized by
GGTase II (see reference 49). Conceivably, either the paired
cysteine motif in Ste18p and Yck1p occurs within a context
that permits GGTase II recognition or another, unidentified
enzyme or auxiliary factor operates on these substrates.
How does dual lipid modification mediate membrane asso-
ciation of yeast Gbg? The failure of the ste18-C106S mutant
protein to accumulate on membranes indicates that palmitoyl-
ation either provides a signal for targeting Ste18p to mem-
branes or contributes to the affinity of Ste18p for membranes.
In vitro, synthetic peptides containing both palmitoyl and far-
nesyl show very slow rates of intermembrane transfer (T1/2 .
50 h) compared with the singly modified peptides (41). Ac-
cording to the bilayer trapping mechanism (2, 38, 41), farne-
sylation of Ste18p may promote weak membrane interactions,
and upon association with a membrane compartment contain-
ing palmitoyltransferase, Ste18p may become palmitoylated
and, thus, anchored at that site. The location of the palmitoyl-
transferase for Ste18p is unknown. In mammalian cells, palmi-
toyltransferase in the plasma membrane modifies Ga (7)
whereas an activity in Golgi membranes palmitoylates a farne-
sylated form of Ras (16). Roles for palmitoylation in both
membrane targeting and membrane affinity have been de-
scribed. Palmitoylation of SNAP-25 is necessary for localiza-
tion of newly synthesized protein at the plasma membrane but
is not required for maintaining fully assembled protein at the
membrane, since brefeldin A blocks both palmitoylation and
membrane targeting of newly synthesized SNAP-25 and since
hydroxylamine hydrolyzes the thioacyl linkage without affect-
ing membrane attachment (14). In contrast, brefeldin A does
not block assembly of mammalian Gbg on the plasma mem-
brane (37), and Ras protein is removed from the plasma mem-
brane upon hydroxylamine treatment (28).
After ligand stimulation and release from Ga, yeast Gbg
(26, 35) as well as many of its mammalian Gbg isoforms (3, 5,
21, 24) are thought to stimulate the activity of effector mole-
cules located on the plasma membrane. The role that Gbg
plays in signal transduction may be simply to promote assembly
of effector molecules at the plasma membrane (35). Thus,
dissociation of Gbg from the plasma membrane provides a
possible mechanism for regulating the duration of Gbg signal-
ing activity. Dissociation could be a consequence of depalmi-
toylation; evidence for reversible palmitoylation of mammalian
Ras exists, and palmitoylation of Ras apparently regulates
plasma membrane attachment (28). Alternatively, a carrier
protein that binds the Gbg complex may shield the lipid groups
from the aqueous environment and thereby permit dissociation
from the membrane. Guanine nucleotide dissociation inhibitor
functions as such a carrier during recycling of geranylgerany-
lated Rab proteins (10, 33). An internal membrane compart-
ment may provide a site where Gbg can reassociate with Ga
before it is reinstated on the plasma membrane. If relevant,
repalmitoylation could occur either in this internal compart-
ment or at the plasma membrane. Clearly, evaluation of these
models will require determination of the palmitoylation state
of Gbg and the presence of specific binding proteins in the
various subcellular compartments.
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